Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Biomea Fusion, Inc. | 42,995 | reported | 30 Nov 2024 | tx 13+624,310 |
| Eidos Therapeutics, Inc. | 0 | reported | 26 Jan 2021 | tx 28+25,513−74,932 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 Nov 2024 | GRANT_AWARD | Biomea Fusion, Inc. | 495 | 6.15 USD | |
| 31 May 2024 | GRANT_AWARD | Biomea Fusion, Inc. | 4,448 | 3.78 USD | |
| 11 Jun 2024 | PURCHASE | Biomea Fusion, Inc. | 12,509 | 4.43 USD | first after silence |
| 17 Jan 2024 | GRANT_AWARD | Biomea Fusion, Inc. | 145,245 | 0.00 USD | deriv |
| 30 Nov 2023 | GRANT_AWARD | Biomea Fusion, Inc. | 1,345 | 3.78 USD | |
| 31 May 2023 | GRANT_AWARD | Biomea Fusion, Inc. | 4,273 | 3.78 USD | |
| 06 Jan 2023 | GRANT_AWARD | Biomea Fusion, Inc. | 126,300 | 0.00 USD | deriv |
| 30 Nov 2022 | GRANT_AWARD | Biomea Fusion, Inc. | 2,518 | 3.78 USD | |
| 11 Nov 2022 | PURCHASE | Biomea Fusion, Inc. | 4,100 | 7.63 USD | |
| 31 May 2022 | GRANT_AWARD | Biomea Fusion, Inc. | 3,307 | 4.67 USD | |
| 14 Jan 2022 | PURCHASE | Biomea Fusion, Inc. | 10,000 | 8.68 USD | |
| 04 Dec 2021 | GRANT_AWARD | Biomea Fusion, Inc. | 144,770 | 0.00 USD | deriv |
| 03 Aug 2021 | GRANT_AWARD | Biomea Fusion, Inc. | 165,000 | 0.00 USD | deriv |
| 26 Jan 2021 | OTHER | Eidos Therapeutics, Inc. | 24,350 | — | deriv |
| 12 Jan 2021 | SALE | Eidos Therapeutics, Inc. | 1,747 | 125.45 USD | |
| 12 Jan 2021 | EXERCISE | Eidos Therapeutics, Inc. | 1,747 | 7.24 USD | |
| 11 Jan 2021 | EXERCISE | Eidos Therapeutics, Inc. | 1,500 | 7.24 USD | |
| 11 Jan 2021 | SALE | Eidos Therapeutics, Inc. | 1,500 | 125.61 USD | |
| 12 Jan 2021 | EXERCISE | Eidos Therapeutics, Inc. | 1,747 | 0.00 USD | deriv |
| 11 Jan 2021 | EXERCISE | Eidos Therapeutics, Inc. | 1,500 | 0.00 USD | deriv |
| 09 Nov 2020 | EXERCISE | Eidos Therapeutics, Inc. | 1,623 | 7.24 USD | |
| 09 Nov 2020 | SALE | Eidos Therapeutics, Inc. | 1,623 | 74.93 USD | |
| 09 Nov 2020 | EXERCISE | Eidos Therapeutics, Inc. | 1,623 | 0.00 USD | deriv |
| 07 Oct 2020 | SALE | Eidos Therapeutics, Inc. | 5,444 | 75.08 USD | |
| 07 Oct 2020 | EXERCISE | Eidos Therapeutics, Inc. | 5,000 | 7.24 USD |
1 purchase reported after at least 12 months of silence — most recent on 11 Jun 2024.